Chemotherapy-induced neutropenia (CIN) is the major dose‑limiting toxicity of systemic
chemotherapy and it is associated with significant morbidity, mortality and treatment cost.
The aim of the present study was to identify the risk factors that may predispose pediatric
cancer patients who receive myelosuppressive chemotherapy to CIN and associated
sequelae. A total of 113 neutropenia episodes were analyzed and the risk factors for CIN
were classified as patient‑specific, disease‑specific and regimen‑specific, while the …

Results Chemotherapy–induced neutropenia (CIN) is the major dose-limiting toxicity of
systemic chemotherapy, and is associated with substantial morbidity, mortality and costs.
The aim of the current work was to identify risk factors that may predispose pediatric cancer
patients, treated with myelo-suppressive chemotherapy, to CIN and associated sequels. 113
neutropenia episodes were analyzed, risk factors for CIN were classified into; patient-
specific, disease-specific and regimen specific while consequences associated with CIN …